Handelsbanken Fonder’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Hold |
38,300
| – | – | ﹤0.01% | 1215 |
|
|
2025
Q1 | $521K | Hold |
38,300
| – | – | ﹤0.01% | 1226 |
|
|
2024
Q4 | $781K | Sell |
38,300
-1,200
| -3% | -$24.5K | ﹤0.01% | 1093 |
|
|
2024
Q3 | $1.15M | Hold |
39,500
| – | – | ﹤0.01% | 885 |
|
|
2024
Q2 | $917K | Buy |
39,500
+15,600
| +65% | +$362K | ﹤0.01% | 877 |
|
|
2024
Q1 | $490K | Hold |
23,900
| – | – | ﹤0.01% | 1170 |
|
|
2023
Q4 | $513K | Buy |
23,900
+6,700
| +39% | +$144K | ﹤0.01% | 1138 |
|
|
2023
Q3 | $355K | Hold |
17,200
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q2 | $508K | Buy |
17,200
+3,100
| +22% | +$91.6K | ﹤0.01% | 1056 |
|
|
2023
Q1 | $325K | Hold |
14,100
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q4 | $392K | Buy |
14,100
+700
| +5% | +$19.5K | ﹤0.01% | 1092 |
|
|
2022
Q3 | $411K | Hold |
13,400
| – | – | ﹤0.01% | 1073 |
|
|
2022
Q2 | $394K | Buy |
13,400
+1,600
| +14% | +$47K | ﹤0.01% | 1165 |
|
|
2022
Q1 | $380K | Sell |
11,800
-6,200
| -34% | -$200K | ﹤0.01% | 1383 |
|
|
2021
Q4 | $803K | Hold |
18,000
| – | – | ﹤0.01% | 1018 |
|
|
2021
Q3 | $908K | Hold |
18,000
| – | – | ﹤0.01% | 953 |
|
|
2021
Q2 | $1.41M | Sell |
18,000
-200
| -1% | -$15.7K | 0.01% | 749 |
|
|
2021
Q1 | $1.04M | Buy |
18,200
+4,100
| +29% | +$234K | 0.01% | 821 |
|
|
2020
Q4 | $1.18M | Hold |
14,100
| – | – | 0.01% | 753 |
|
|
2020
Q3 | $505K | Hold |
14,100
| – | – | ﹤0.01% | 986 |
|
|
2020
Q2 | $341K | Buy |
+14,100
| New | +$341K | ﹤0.01% | 1153 |
|